Anna Supernat
Anna Supernat is an expert in Oncology at University of Gdańsk (Poland). Anna Supernat has authored 50 publications, the most recent in 2026. SLR score: 164 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Hematology - Genetics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2026
Number : 50
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Deepening the Understanding of Platelet-Derived RNA as Biomarker for Glioblastoma Through GSEA, TDEA, and Elastic Net Regularization Analysis. PMID 42816786 — neoplasms, biomarkers, glioblastoma, blood platelets, tumor microenvironment | Cancer Rep (Hoboken) | 2026 | 0 |
| Exploring platelet-covered and naked circulating tumor cells - a single-cell transcriptomic perspective. PMID 42443915 — cells, genes, blood, neoplastic cells, circulating, breast neoplasms, biomedical research, ovary, neoplasms, breast, blood platelets | J Transl Med | 2026 | 0 |
| Reframing Response in Neoadjuvant Chemotherapy for Ovarian Cancer: Integrating Molecular and Functional Biomarkers. PMID 42437630 — ovary, neoplasms, biopsy, drug therapy, biomarkers, machine learning, ovarian neoplasms, therapeutics, learning, liquid biopsy, chemotherapy, digital twin | Crit Rev Oncol Hematol | 2026 | 0 |
| Decoding circulating neutrophil phenotypes in triple-negative breast cancer via optimized single-cell RNA sequencing. PMID 42154046 — cells, genes, triple negative breast neoplasms, breast neoplasms, neoplasms, phenotype, neutrophils, immunotherapy, breast, work, rna | Cancer Immunol Immunother | 2026 | 0 |
| Case Report: Blood single-cell analysis of a IVB high-grade serous ovarian cancer patient presenting a favorable prognosis. PMID 41367869 — cells, up-regulation, genes, blood, neoplasms, phenotype, biopsy, ovarian neoplasms, single-cell analysis, therapeutics, down-regulation, liquid biopsy, prognosis | Front Oncol | 2025 | 0 |
LeadR Networks
Main global connection map